• PDF: Delivered by email usually within 48 UK business hours.

Drug Delivery Devices Market Outlook in Belgium to 2017
Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections

  • Publication Date:May 2011
  • Publisher:GlobalData
  • Product Type: Report
  • Pages:112

Drug Delivery Devices Market Outlook in Belgium to 2017 Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections

Drug Delivery Devices Market Outlook in Belgium to 2017- Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections

Summary

GlobalData's new report, "Drug Delivery Devices Market Outlook in Belgium to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections" provides key market data on the Belgium Drug Delivery Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within four market categories - Central Venous Catheters, Infusion Systems, Metered Dose Inhaler Devices and Needle Free Injections. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

  • Market size and company share data for Drug Delivery Devices market categories - Central Venous Catheters, Infusion Systems, Metered Dose Inhaler Devices and Needle Free Injections.
  • Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within four market categories. Data from 2003 to 2010, forecast forward for 7 years to 2017.
  • 2010 company shares and distribution shares data for each of the four market categories.
  • Global corporate-level profiles of key companies operating within the Belgium Drug Delivery Devices market.
  • Key players covered include GlaxoSmithKline plc, Boehringer Ingelheim GmbH, AstraZeneca PLC, Baxter International Inc., CareFusion Corporation, B. Braun Melsungen AG and others.

Reasons to buy

  • Develop business strategies by identifying the key market categories and segments poised for strong growth.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the Belgium Drug Delivery Devices competitive landscape.
  • Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.
  • 1 Table of Contents
    • 1.1 List of Tables
    • 1.2 List of Figures
  • 2 Introduction
    • 2.1 What is This Report About?
  • 3 Drug Delivery Devices In Belgium
    • 3.1 Drug Delivery Devices, Market Segmentation
    • 3.2 Drug Delivery Devices, Belgium, Overall Revenue ($m), 2003-2017
    • 3.3 Drug Delivery Devices Market, Belgium, Revenue Mix ($m), 2010
    • 3.4 Drug Delivery Devices Market, Belgium, Category Contribution (%), 2010
    • 3.5 Drug Delivery Devices, Belgium, Category Volume (Units), 2003-2017
    • 3.6 Drug Delivery Devices, Belgium, Company Share (2009-2010)
  • 4 Central Venous Catheters In Belgium
    • 4.1 Central Venous Catheters, Market Segmentation
    • 4.2 Central Venous Catheters Market, Belgium, Revenue Mix ($m), 2010
    • 4.3 Central Venous Catheters Market, Belgium, Segment Contribution (%), 2010
    • 4.4 Central Venous Catheters Overall Revenue (2003-2017)
    • 4.5 Central Venous Catheters Overall Volume (2003-2017)
    • 4.6 Central Venous Catheters Average Price (2003-2017)
    • 4.7 Central Venous Catheters Distribution Share (2009-2010)
    • 4.8 Central Venous Catheters, Belgium, Company Share (2009-2010)
  • 5 Infusion Systems In Belgium
    • 5.1 Infusion Systems, Market Segmentation
    • 5.2 Infusion Systems Market, Belgium, Revenue Mix ($m), 2010
    • 5.3 Infusion Systems Market, Belgium, Segment Contribution (%), 2010
    • 5.4 Infusion Systems Overall Revenue (2003-2017)
    • 5.4.1 Syringe Pumps Revenue (2003-2017)
    • 5.4.2 Ambulatory Infusion Pumps Revenue (2003-2017)
    • 5.5 Infusion Systems Overall Volume (2003-2017)
    • 5.5.1 Syringe Pumps Volume (2003-2017)
    • 5.5.2 Ambulatory Infusion Pumps Volume (2003-2017)
    • 5.6 Infusion Systems Average Price (2003-2017)
    • 5.7 Infusion Systems Distribution Share (2009-2010)
    • 5.8 Infusion Systems, Belgium, Company Share (2009-2010)
  • 6 Metered Dose Inhaler Devices In Belgium
    • 6.1 Metered Dose Inhaler Devices Overall Revenue (2003-2017)
    • 6.2 Metered Dose Inhaler Devices Overall Volume (2003-2017)
    • 6.3 Metered Dose Inhaler Devices Average Price (2003-2017)
    • 6.4 Metered Dose Inhaler Devices Distribution Share (2009-2010)
    • 6.5 Metered Dose Inhaler Devices, Belgium, Company Share (2009-2010)
  • 7 Needle Free Injections In Belgium
    • 7.1 Needle Free Injections Overall Revenue (2003-2017)
    • 7.2 Needle Free Injections Overall Volume (2003-2017)
    • 7.3 Needle Free Injections Average Price (2003-2017)
    • 7.4 Needle Free Injections Distribution Share (2009-2010)
    • 7.5 Needle Free Injections, Belgium, Company Share (2009-2010)
  • 8 Overview of Key Companies in Belgium Drug Delivery Devices Market
    • 8.1 GlaxoSmithKline plc
    • 8.1.1 Company Overview
    • 8.1.2 Share in the Belgium Drug Delivery Devices Market
    • 8.2 Boehringer Ingelheim GmbH
    • 8.2.1 Company Overview
    • 8.2.2 Share in the Belgium Drug Delivery Devices Market
    • 8.3 AstraZeneca PLC
    • 8.3.1 Company Overview
    • 8.3.2 Share in the Belgium Drug Delivery Devices Market
    • 8.4 Baxter International Inc
    • 8.4.1 Company Overview
    • 8.4.2 Share in the Belgium Drug Delivery Devices Market
    • 8.5 CareFusion Corporation
    • 8.5.1 Company Overview
    • 8.5.2 Share in the Belgium Drug Delivery Devices Market
    • 8.6 B. Braun Melsungen AG
    • 8.6.1 Company Overview
    • 8.6.2 Share in the Belgium Drug Delivery Devices Market
    • 8.7 Hospira, Inc
    • 8.7.1 Company Overview
    • 8.8 Medtronic, Inc
    • 8.8.1 Company Overview
    • 8.9 Teleflex Incorporated
    • 8.9.1 Company Overview
    • 8.10 Fresenius Kabi AG
    • 8.10.1 Company Overview
    • 8.11 Terumo Corporation
    • 8.11.1 Company Overview
    • 8.12 Smiths Medical
    • 8.12.1 Company Overview
    • 8.13 Edwards Lifesciences Corporation
    • 8.13.1 Company Overview
    • 8.14 3M Health Care
    • 8.14.1 Company Overview
    • 8.15 Consort Medical plc
    • 8.15.1 Company Overview
    • 8.16 Becton, Dickinson and Company
    • 8.16.1 Company Overview
    • 8.17 C. R. Bard, Inc
    • 8.17.1 Company Overview
    • 8.18 Bioject Medical Technologies Inc
    • 8.18.1 Company Overview
    • 8.19 Antares Pharma, Inc
    • 8.19.1 Company Overview
    • 8.20 INJEX - Equidyne Systems
    • 8.20.1 Company Overview
  • 9 Drug Delivery Devices Market Pipeline Products
  • 10 Appendix
    • 10.1 Definitions of Markets Covered in the Report
    • 10.1.1 Drug Delivery Devices
    • 10.2 Research Methodology
    • 10.3 Secondary Research
    • 10.4 Primary Research
    • 10.5 Models
    • 10.6 Forecasts
    • 10.7 Expert Panels
    • 10.8 GlobalData Consulting
    • 10.9 Currency Conversion
    • 10.10 Contact Us
    • 10.11 Disclaimer
  • 1.1 List of Tables
    • Table 1: Drug Delivery Devices, Belgium, Overall Revenue ($m), 2003-2017
    • Table 2: Drug Delivery Devices Market, Belgium, Category Contribution (%), 2010
    • Table 3: Drug Delivery Devices, Belgium Cross-Category Analysis, 2003-2017
    • Table 4: Drug Delivery Devices, Belgium, Overall Revenue ($m), Historic, 2003-2010
    • Table 5: Drug Delivery Devices, Belgium, Overall Revenue ($m), Forecast, 2010-2017
    • Table 6: Drug Delivery Devices, Belgium, Category Volume (Units), 2003-2017
    • Table 7: Drug Delivery Devices, Belgium, Category Volume (Units), Historic, 2003-2010
    • Table 8: Drug Delivery Devices, Belgium, Category Volume (Units), Forecast, 2010-2017
    • Table 9: Drug Delivery Devices, Belgium, Company Share by Revenue ($m), 2009-2010
    • Table 10: Central Venous Catheters Market, Belgium, Segment Contribution (%), 2010
    • Table 11: Central Venous Catheters, Belgium, Revenue ($m) by Segment, Historic, 2003-2010
    • Table 12: Central Venous Catheters, Belgium, Revenue ($m) by Segment, Forecast, 2010-2017
    • Table 13: Central Venous Catheters, Belgium, Volume (Units) by Segment, Historic, 2003-2010
    • Table 14: Central Venous Catheters, Belgium, Volume (Units) by Segment, Forecast, 2010-2017
    • Table 15: Central Venous Catheters, Belgium, Average Price ($), Historic, 2003-2010
    • Table 16: Central Venous Catheters, Belgium, Average Price ($), Forecast, 2010-2017
    • Table 17: Central Venous Catheters, Belgium, Distribution Share by Revenue ($m), 2009-2010
    • Table 18: Central Venous Catheters, Belgium, Company Share by Revenue ($m), 2009-2010
    • Table 19: Infusion Systems Market, Belgium, Segment Contribution (%), 2010
    • Table 21: Infusion Systems, Belgium, Revenue ($m) by Segment, Historic, 2003-2010
    • Table 22: Infusion Systems, Belgium, Revenue ($m) by Segment, Forecast, 2010-2017
    • Table 23: Syringe Pumps, Belgium, Revenue ($m) by Sub-Segment, Historic, 2003-2010
    • Table 24: Syringe Pumps, Belgium, Revenue ($m) by Sub-Segment, Forecast, 2010-2017
    • Table 25: Ambulatory Infusion Pumps, Belgium, Revenue ($m) by Sub-Segment, Historic, 2003-2010
    • Table 26: Ambulatory Infusion Pumps, Belgium, Revenue ($m) by Sub-Segment, Forecast, 2010-2017
    • Table 27: Infusion Systems, Belgium, Volume (Units) by Segment, Historic, 2003-2010
    • Table 28: Infusion Systems, Belgium, Volume (Units) by Segment, Forecast, 2010-2017
    • Table 29: Syringe Pumps, Belgium, Volume (Units) by Sub-Segment, Historic, 2003-2010
    • Table 30: Syringe Pumps, Belgium, Volume (Units) by Sub-Segment, Forecast, 2010-2017
    • Table 31: Ambulatory Infusion Pumps, Belgium, Volume (Units) by Sub-Segment, Historic, 2003-2010
    • Table 32: Ambulatory Infusion Pumps, Belgium, Volume (Units) by Sub-Segment, Forecast, 2010-2017
    • Table 33: Infusion Systems, Belgium, Average Price ($), Historic, 2003-2010
    • Table 34: Infusion Systems, Belgium, Average Price ($), Forecast, 2010-2017
    • Table 35: Infusion Systems, Belgium, Distribution Share by Revenue ($m), 2009-2010
    • Table 36: Infusion Systems, Belgium, Company Share by Revenue ($m), 2009-2010
    • Table 37: Metered Dose Inhaler Devices, Belgium, Revenue ($m), Historic, 2003-2010
    • Table 38: Metered Dose Inhaler Devices, Belgium, Revenue ($m), Forecast, 2010-2017
    • Table 39: Metered Dose Inhaler Devices, Belgium, Volume (Units), Historic, 2003-2010
    • Table 40: Metered Dose Inhaler Devices, Belgium, Volume (Units), Forecast, 2010-2017
    • Table 41: Metered Dose Inhaler Devices, Belgium, Average Price ($), Historic, 2003-2010
    • Table 42: Metered Dose Inhaler Devices, Belgium, Average Price ($), Forecast, 2010-2017
    • Table 43: Metered Dose Inhaler Devices, Belgium, Distribution Share by Revenue ($m), 2009-2010
    • Table 44: Metered Dose Inhaler Devices, Belgium, Company Share by Revenue ($m), 2009-2010
    • Table 45: Needle Free Injections, Belgium, Revenue ($m), Historic, 2003-2010
    • Table 46: Needle Free Injections, Belgium, Revenue ($m), Forecast, 2010-2017
    • Table 47: Needle Free Injections, Belgium, Volume (Units), Historic, 2003-2010
    • Table 48: Needle Free Injections, Belgium, Volume (Units), Forecast, 2010-2017
    • Table 49: Needle Free Injections, Belgium, Average Price ($), Historic, 2003-2010
    • Table 50: Needle Free Injections, Belgium, Average Price ($), Forecast, 2010-2017
    • Table 51: Needle Free Injections, Belgium, Distribution Share by Revenue ($m), 2009-2010
    • Table 52: Needle Free Injections, Belgium, Company Share by Revenue ($m), 2009-2010
    • Table 53: Drug Delivery Devices Market Pipeline Products
    • Table 54: USD to Local Currency, Belgium, Average Actual Rate 2003-2010
  • 1.2 List of Figures
    • Figure 1: Drug Delivery Devices, Market Segmentation
    • Figure 2: Drug Delivery Devices, Belgium, Overall Revenue ($m), 2003-2017
    • Figure 3: Drug Delivery Devices Market, Belgium, Revenue Mix ($m), 2010
    • Figure 4: Drug Delivery Devices Market, Belgium, Category Contribution (%), 2010
    • Figure 5: Drug Delivery Devices Market, Belgium, Cross-Category Analysis, 2003-2017
    • Figure 6: Drug Delivery Devices, Belgium, Overall Revenue ($m), Historic, 2003-2010
    • Figure 7: Drug Delivery Devices, Belgium, Overall Revenue ($m), Forecast, 2010-2017
    • Figure 8: Drug Delivery Devices, Belgium, Category Volume (Units), 2003-2017
    • Figure 9: Drug Delivery Devices, Belgium, Category Volume (Units), Historic, 2003-2010
    • Figure 10: Drug Delivery Devices, Belgium, Category Volume (Units), Forecast, 2010-2017
    • Figure 11: Drug Delivery Devices, Belgium, Company Share (%), 2010
    • Figure 12: Central Venous Catheters, Market Segmentation
    • Figure 13: Central Venous Catheters Market, Belgium, Revenue Mix ($m), 2010
    • Figure 14: Central Venous Catheters Market, Belgium, Segment Contribution (%), 2010
    • Figure 15: Central Venous Catheters, Belgium, Revenue ($m) by Segment, Historic, 2003-2010
    • Figure 16: Central Venous Catheters, Belgium, Revenue ($m) by Segment, Forecast, 2010-2017
    • Figure 17: Central Venous Catheters, Belgium, Volume (Units) by Segment, Historic, 2003-2010
    • Figure 18: Central Venous Catheters, Belgium, Volume (Units) by Segment, Forecast, 2010-2017
    • Figure 19: Central Venous Catheters, Belgium, Company Share (%), 2010
    • Figure 20: Infusion Systems, Market Segmentation
    • Figure 21: Infusion Systems Market, Belgium, Revenue Mix ($m), 2010
    • Figure 22: Infusion Systems Market, Belgium, Segment Contribution (%), 2010
    • Figure 23: Infusion Systems, Belgium, Revenue ($m) by Segment, Historic, 2003-2010
    • Figure 24: Infusion Systems, Belgium, Revenue ($m) by Segment, Forecast, 2010-2017
    • Figure 25: Syringe Pumps, Belgium, Revenue ($m) by Sub-Segment, Historic, 2003-2010
    • Figure 26: Syringe Pumps, Belgium, Revenue ($m) by Sub-Segment, Forecast, 2010-2017
    • Figure 27: Ambulatory Infusion Pumps, Belgium, Revenue ($m) by Sub-Segment, Historic, 2003-2010
    • Figure 28: Ambulatory Infusion Pumps, Belgium, Revenue ($m) by Sub-Segment, Forecast, 2010-2017
    • Figure 29: Infusion Systems, Belgium, Volume (Units) by Segment, Historic, 2003-2010
    • Figure 30: Infusion Systems, Belgium, Volume (Units) by Segment, Forecast, 2010-2017
    • Figure 31: Syringe Pumps, Belgium, Volume (Units) by Sub-Segment, Historic, 2003-2010
    • Figure 32: Syringe Pumps, Belgium, Volume (Units) by Sub-Segment, Forecast, 2010-2017
    • Figure 33: Ambulatory Infusion Pumps, Belgium, Volume (Units) by Sub-Segment, Historic, 2003-2010
    • Figure 34: Ambulatory Infusion Pumps, Belgium, Volume (Units) by Sub-Segment, Forecast, 2010-2017
    • Figure 35: Infusion Systems, Belgium, Company Share (%), 2010
    • Figure 36: Metered Dose Inhaler Devices, Belgium, Revenue ($m), Historic, 2003-2010
    • Figure 37: Metered Dose Inhaler Devices, Belgium, Revenue ($m), Forecast, 2010-2017
    • Figure 38: Metered Dose Inhaler Devices, Belgium, Volume (Units), Historic, 2003-2010
    • Figure 39: Metered Dose Inhaler Devices, Belgium, Volume (Units), Forecast, 2010-2017
    • Figure 40: Metered Dose Inhaler Devices, Belgium, Company Share (%), 2010
    • Figure 41: Needle Free Injections, Belgium, Revenue ($m), Historic, 2003-2010
    • Figure 42: Needle Free Injections, Belgium, Revenue ($m), Forecast, 2010-2017
    • Figure 43: Needle Free Injections, Belgium, Volume (Units), Historic, 2003-2010
    • Figure 44: Needle Free Injections, Belgium, Volume (Units), Forecast, 2010-2017
    • Figure 45: Needle Free Injections, Belgium, Company Share (%), 2010
    • Figure 46: GlaxoSmithKline plc, Company Share (%),Belgium Drug Delivery Devices Market, 2010
    • Figure 47: Boehringer Ingelheim GmbH, Company Share (%),Belgium Drug Delivery Devices Market, 2010
    • Figure 48: AstraZeneca PLC., Company Share (%),Belgium Drug Delivery Devices Market, 2010
    • Figure 49: Baxter International Inc., Company Share (%),Belgium Drug Delivery Devices Market, 2010
    • Figure 50: CareFusion Corporation, Company Share (%),Belgium Drug Delivery Devices Market, 2010
    • Figure 51: B. Braun Melsungen AG, Company Share (%),Belgium Drug Delivery Devices Market, 2010
+44 20 8816 8548

Ask a question about Drug Delivery Devices Market Outlook in Belgium to 2017

Enter the characters you see in the picture below
Captcha